Marcus Heldmann Selected Research

Marcus Heldmann Research Topics

8	Parkinson Disease (Parkinson's Disease) 02/2024 - 06/2008
2	Atrophy 01/2023 - 10/2019
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2023 - 01/2022
2	Body Weight (Weight, Body) 06/2022 - 01/2022
2	Movement Disorders (Movement Disorder) 01/2021 - 05/2017
2	Hypothyroidism 01/2019 - 01/2019
2	Alcoholism (Alcohol Abuse) 01/2012 - 01/2009
2	Gambling (Pathological Gambling) 01/2012 - 06/2008
1	X-Linked Torsion Dystonia 3 01/2023
1	Epilepsy (Aura) 06/2022
1	Migraine Disorders (Migraine) 06/2022
1	Overweight 06/2022
1	Cognitive Dysfunction 01/2021
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2020
1	Tremor (Tremors) 10/2019
1	Breast Neoplasms (Breast Cancer) 09/2019
1	Aspiration Pneumonia 09/2019
1	Quadriplegia (Spastic Quadriplegia) 09/2019
1	Motor Neuron Disease (Primary Lateral Sclerosis) 09/2019
1	Leukoencephalopathies 09/2019
1	Perceptual Disorders (Hemispatial Neglect) 01/2019
1	Task-Specific Focal Dystonia 04/2016
1	Disruptive, Impulse Control, and Conduct Disorders (Kleptomania) 11/2015
1	Obesity 06/2012

2	IronIBA 01/2023 - 10/2019
2	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2019 - 01/2019
2	Dopamine Agonists (Dopamine Agonist)IBA 11/2015 - 06/2008
1	Dopamine Agents (Dopaminergic Agents)IBA 02/2024
1	salicylhydroxamic acid (SHAM)IBA 06/2022
1	neuromelaninIBA 01/2021
1	Thyroid HormonesIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Dopamine (Intropin)FDA LinkGeneric 10/2019
1	Capecitabine (Xeloda)FDA Link 09/2019
1	Therapeutic UsesIBA 01/2019
1	Appetite Depressants (Anorectics)IBA 06/2012
1	sibutramine (Meridia)FDA Link 06/2012

7	Deep Brain Stimulation 01/2022 - 07/2008
5	Therapeutics 01/2023 - 11/2015
1	Vagus Nerve Stimulation 06/2022
1	Drug Therapy (Chemotherapy) 09/2019
1	Transcranial Magnetic Stimulation 04/2016
1	Electrodes (Electrode) 07/2008